Updates are available Correction dated 2020-08-11

Article History

First Online: 4 August 2020

Change Date: 16 February 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1038/s41581-020-00341-y

Competing interests

: J.C.Q.V. has participated in Advisory Board meetings for Mallinckrodt Pharmaceuticals and Retrophin and is a member of the Speaker Bureau for Otsuka Pharmaceuticals. None of the products related to those engagements are discussed in this manuscript. T.C. and C.P.L are employees of Arkana Laboratories, which is a vendor of <i>APOL1</i> genotype clinical testing.

Free to read: This content has been made available to all.